High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma

Abstract excerpt

The childhood cancer neuroblastoma arises in the developing sympathetic nervous system and is a genotypically and phenotypically heterogeneous disease. Prognostic markers of poor survival probability include amplification of the MYCN oncogene and an undifferentiated morphology. Whereas these features discriminate high- from low-risk patients with precision, identification of poor outcome low- and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer, Hypoxia, and Metabolism
• Share to Mitochondrial Function and Pathology
• Share to Neuroblastoma Research and Treatments